touchOPTHALMOLOGY spoke to Christine Kay at AAO 2018 regarding her long-running course titled 'Retinal Frontiers: Updates in Gene Therapy and Stem Cell Therapy', as well as her most exciting advances and trials in gene and stem cell therapy and her key highlights from this year's meeting.
1. Please tell us about your course at this year's AAO meeting, 'Retinal Frontiers: Updates in Gene Therapy and Stem Cell Therapy'. (0:11)
2. What do you think is the most exciting upcoming advance or trial in gene and stem cell therapy? (1:58)
3. What are your key highlights from this year's AAO meeting? (3:26)
Speaker disclosures: Christine Nichols Kay is a consultant for Spark Therapeutics, an investigator for Alkeus and Foundation for Fighting Blindness and a consultant/investigator for AGTC.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.